SynthesisBiomolecules2023

Dupilumab Leads to Clinical Improvements including the Acquisition of Tolerance to Causative Foods in Non-Eosinophilic Esophagitis Eosinophilic Gastrointestinal Disorders.

Naoya Arakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.